Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ujwani Nukala"'
Autor:
Stephen A. Shrum, Ujwani Nukala, Shivangi Shrimali, Edith Nathalie Pineda, Kimberly J. Krager, Shraddha Thakkar, Darin E. Jones, Rupak Pathak, Philip J. Breen, Nukhet Aykin-Burns, Cesar M. Compadre
Publikováno v:
Antioxidants, Vol 12, Iss 11, p 1987 (2023)
Tocotrienols have powerful radioprotective properties in multiple organ systems and are promising candidates for development as clinically effective radiation countermeasures. To facilitate their development as clinical radiation countermeasures, it
Externí odkaz:
https://doaj.org/article/025774aeb31a47a8886e67dfde8f0adf
Autor:
Marisabel Rodriguez Messan, Osman N Yogurtcu, Joseph R McGill, Ujwani Nukala, Zuben E Sauna, Hong Yang
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 9, p e1009318 (2021)
Cancer vaccines are an important component of the cancer immunotherapy toolkit enhancing immune response to malignant cells by activating CD4+ and CD8+ T cells. Multiple successful clinical applications of cancer vaccines have shown good safety and e
Externí odkaz:
https://doaj.org/article/34612679abed4dbf841986552536e7d1
Autor:
Ujwani Nukala, Shraddha Thakkar, Kimberly J. Krager, Philip J. Breen, Cesar M. Compadre, Nukhet Aykin-Burns
Publikováno v:
Antioxidants, Vol 7, Iss 2, p 33 (2018)
Radiation countermeasures fall under three categories, radiation protectors, radiation mitigators, and radiation therapeutics. Radiation protectors are agents that are administered before radiation exposure to protect from radiation-induced injuries
Externí odkaz:
https://doaj.org/article/d8fe0c4a42a14c64bec61c1885e0453d
Autor:
Jane Namangolwa Mutanga, Ujwani Nukala, Marisabel Rodriguez Messan, Osman N. Yogurtcu, Quinn McCormick, Zuben E. Sauna, Barbee I. Whitaker, Richard A. Forshee, Hong Yang
Publikováno v:
The AAPS Journal. 25
Advances in genetic engineering have made it possible to reprogram an individual’s immune cells to express receptors that recognize markers on tumor cell surfaces. The process of re-engineering T cell lymphocytes to express Chimeric Antigen Recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a5f587ec1bc787a1af58ff5e858128f
https://doi.org/10.1101/2022.12.01.22282976
https://doi.org/10.1101/2022.12.01.22282976
Publikováno v:
Mathematical Biosciences. 356:108966
Chimeric Antigen Receptor (CAR) T-cell therapy is an immunotherapy that has recently become highly instrumental in the fight against life-threatening diseases. A variety of modeling and computational simulation efforts have addressed different aspect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e276f753815b7e77e5641792b86ea2c
http://arxiv.org/abs/2101.05359
http://arxiv.org/abs/2101.05359
Autor:
Shraddha Thakkar, Philip J. Breen, Cesar M. Compadre, Nukhet Aykin-Burns, Ujwani Nukala, Kimberly J. Krager
Publikováno v:
Antioxidants, Vol 7, Iss 2, p 33 (2018)
Antioxidants
Antioxidants
Radiation countermeasures fall under three categories, radiation protectors, radiation mitigators, and radiation therapeutics. Radiation protectors are agents that are administered before radiation exposure to protect from radiation-induced injuries